Development and validation of a lung cancer risk prediction model

Principal Investigator

Name
Martin Tammemagi

Degrees
DVM; MSc; PhD

Institution
Henry Ford Health System

Position Title
Professor of Epidemiology

Email
martin.tammemagi@brocku.ca

About this CDAS Project

Study
NLST (Learn more about this study)

Project ID
201110-0018

Initial CDAS Request Approval
Oct 25, 2011

Title
Development and validation of a lung cancer risk prediction model

Summary
The general purpose of this study is to attempt to validate and further enhance a lung cancer risk prediction model developed in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial data. The PLCO model is describe in the following paper: Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. Journal of the National Cancer Institute 2011;103(13):1058-68.

Collaborators

Gerard Silvestri

Related Publications

• Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
  Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD
  PLoS Med. 2014 Dec; Volume 11 (Issue 12): Pages e1001764 PUBMED
• Selection criteria for lung-cancer screening.
  Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD
  N. Engl. J. Med. 2013 Feb; Volume 368 (Issue 8): Pages 728-36 PUBMED